Plasma levels of transforming growth factor beta 1 in chronic liver disease

被引：11
|
作者：
Hayasaka, A [1 ]
Suzuki, N [1 ]
Fukuyama, E [1 ]
Kanda, Y [1 ]
机构：
[1] KIMITSU CHUO HOSP,DEPT MED,CHIBA,JAPAN
来源：
CLINICA CHIMICA ACTA | 1996年 / 244卷 / 01期
关键词：
transforming growth factor beta 1; chronic liver disease; plasma marker;
D O I：
10.1016/0009-8981(95)06201-7
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：117 / 119
页数：3
相关论文
共 50 条
  • [21] Nitric oxide levels in chronic liver disease patients with and without oesophageal varices
    El-Sherif, Assem M.
    Abou-Shady, Mohamed A.
    Al-Bahrawy, Ashraf M.
    Bakr, Reda M.
    Hosny, Abdel-Moneim M.
    HEPATOLOGY INTERNATIONAL, 2008, 2 (03) : 341 - 345
  • [22] Nitric oxide levels in chronic liver disease patients with and without oesophageal varices
    Assem M. El-Sherif
    Mohamed A. Abou-Shady
    Ashraf M. Al-Bahrawy
    Reda M. Bakr
    Abdel-Moneim M. Hosny
    Hepatology International, 2008, 2
  • [23] Therapeutic potential of macrophage colony-stimulating factor in chronic liver disease
    Keshvari, Sahar
    Genz, Berit
    Teakle, Ngari
    Caruso, Melanie
    Cestari, Michelle F.
    Patkar, Omkar L.
    Tse, Brian W. C.
    Sokolowski, Kamil A.
    Ebersbach, Hilmar
    Jascur, Julia
    MacDonald, Kelli P. A.
    Miller, Gregory
    Ramm, Grant A.
    Pettit, Allison R.
    Clouston, Andrew D.
    Powell, Elizabeth E.
    Hume, David A.
    Irvine, Katharine M.
    DISEASE MODELS & MECHANISMS, 2022, 15 (04)
  • [24] INCREASES IN SERUM BETA-3 INTEGRIN IN PATIENTS WITH CHRONIC LIVER-DISEASE
    YAMAUCHI, M
    MIZUHARA, Y
    TAKAHASHI, A
    TODA, G
    CLINICA CHIMICA ACTA, 1994, 225 (01) : 71 - 76
  • [25] Evaluation of plasma ammonia levels in patients with acute liver failure and chronic liver disease and its correlation with the severity of hepatic encephalopathy and clinical features of raised intracranial tension
    Kundra, A
    Jain, A
    Banga, A
    Bajaj, G
    Kar, P
    CLINICAL BIOCHEMISTRY, 2005, 38 (08) : 696 - 699
  • [26] Safety of long-term lopinavir plasma-levels in patients with liver disease
    Langmann, P.
    Hubert, C.
    Heinz, W.
    Trein, A.
    Schnaitmann, E.
    Leyh, M.
    Klinker, H.
    Winzer, R.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2008, 13 (05) : 205 - 208
  • [27] Fibroblast growth factor 21 in non-alcoholic fatty liver disease
    Tucker, Bradley
    Li, Huating
    Long, Xiaoxue
    Rye, Kerry-Anne
    Ong, Kwok Leung
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 101
  • [28] Sodium and Calcium Levels as a Predictor for Hepatic Encephalopathy in Pediatric Patients with Chronic Liver Disease
    Khalesi, Maryam
    Kianifar, Hamid Reza
    Entezari, Davoud
    Chaichi, Zahra
    INTERNATIONAL JOURNAL OF PEDIATRICS-MASHHAD, 2022, 10 (03): : 15594 - 15600
  • [29] The role of vascular endothelial growth factor-634 G/C and its soluble receptor on chronic liver disease and hepatocellular carcinoma
    Ratnasari, Neneng
    Nurdjanah, Siti
    Sadewa, Ahmad H.
    Hakimi, Mohammad
    ARAB JOURNAL OF GASTROENTEROLOGY, 2016, 17 (02) : 61 - 66
  • [30] Plasma from chronic liver disease subjects exhibit differential ability to generate thrombin
    Yang, Zhineng J.
    Sheth, Siddharth H.
    Smith, Chad H.
    Schmotzer, Amy R.
    Lippello, Anita L.
    Al-Khafaji, Ali
    Chopra, Kapil B.
    Smith, Roy E.
    BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (07) : 844 - 847
12345